This announcement is a separate document:
景峰医药：广发证券股份有限公司关于湖南景峰医药股份有限公司重大资产出售及发行股份购买资产并募集配套资金暨关联交易之2022 年度募集资金存放与使用情况的核查意见
Jingfeng Pharmaceutical: Audit opinion of Guangfa Securities Co., Ltd. on the storage and use of funds raised in 2022 for the sale and issuance of shares of major assets of Hunan Jingfeng Pharmaceutical Co., Ltd., to purchase assets and raise supporting fu
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.